Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.

Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.

BACKGROUND: HER2 and TOP2A gene status are assessed for diagnostic and research purposes in breast cancer with fluorescence in situ hybridization (FISH). However, FISH probes do not target only the annotated gene, while chromosome 17 (chr17) is among the most unstable chromosomes in breast cancer. H...

Full description

Bibliographic Details
Main Authors:	Vassiliki Kotoula, Mattheos Bobos, Zoi Alexopoulou, Christos Papadimitriou, Kyriaki Papadopoulou, Elpida Charalambous, Eleftheria Tsolaki, Grigorios Xepapadakis, Irene Nicolaou, Irene Papaspirou, Gerasimos Aravantinos, Christos Christodoulou, Ioannis Efstratiou, Helen Gogas, George Fountzilas
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4123879?pdf=render

Similar Items

Evaluation of two highly-multiplexed custom panels for massively parallel semiconductor sequencing on paraffin DNA.
by: Vassiliki Kotoula, et al.
Published: (2015-01-01)

Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.
by: Vassiliki Kotoula, et al.
Published: (2016-01-01)

Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study.
by: George Papaxoinis, et al.
Published: (2015-01-01)

Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).
by: George Pentheroudakis, et al.
Published: (2013-01-01)

Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab
by: Fountzilas George, et al.
Published: (2012-10-01)

HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy
by: Fountzilas George, et al.
Published: (2012-01-01)

Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.
by: Vassiliki Kotoula, et al.
Published: (2009-11-01)

Protein expression patterns of cell cycle regulators in operable breast cancer.
by: Flora Zagouri, et al.
Published: (2017-01-01)

Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer
by: Murray Samuel, et al.
Published: (2012-09-01)

Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
by: Angelos Koutras, et al.
Published: (2018-01-01)

Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG)
by: Vassiliki Kotoula, et al.
Published: (2019-09-01)

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer
by: Elena Fountzilas, et al.
Published: (2019-04-01)

MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer
by: George Fountzilas, et al.
Published: (2009-01-01)

Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?
by: Elena Fountzilas, et al.
Published: (2021-06-01)

A Splice Variant of HER2 Corresponding to Herstatin Is Expressed in the Noncancerous Breast and in Breast Carcinomas
by: Triantafyllia Koletsa, et al.
Published: (2008-07-01)

Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer.
by: Genovefa Polychronidou, et al.
Published: (2018-01-01)

Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial.
by: George Fountzilas, et al.
Published: (2013-01-01)

Comparison of somatic variant detection algorithms using Ion Torrent targeted deep sequencing data
by: Qing Wang, et al.
Published: (2019-12-01)

Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study.
by: Flora Stavridi, et al.
Published: (2016-01-01)

Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab
by: Panagiota Economopoulou, et al.
Published: (2019-05-01)

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
by: Briasoulis Evangelos, et al.
Published: (2010-01-01)

Treating EGFR-Mutated Oncogene-Addicted Advanced Non–Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities
by: Elena Fountzilas, et al.
Published: (2018-09-01)

Correction: Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases
by: Alexandra V. Stavropoulou, et al.
Published: (2013-01-01)

Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases.
by: Alexandra V Stavropoulou, et al.
Published: (2013-01-01)

Correction: Prevalence of Mutations in Familial and Sporadic Greek Ovarian Cancer Cases.
by: Alexandra V. Stavropoulou, et al.
Published: (2013-01-01)

Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy
by: Eleni Timotheadou, et al.
Published: (2017-08-01)

Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
by: Anna Goussia, et al.
Published: (2018-01-01)

<i>CHEK2</i> Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects
by: Paraskevi Apostolou, et al.
Published: (2021-04-01)

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study
by: Efstratiou Ioannis, et al.
Published: (2011-01-01)

Outcomes and Quality of Life of Systemic Therapy in Advanced Hepatocellular Carcinoma
by: Kehua Zhou, et al.
Published: (2019-06-01)

Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study
by: Samuel Murray, et al.
Published: (2010-01-01)

Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.
by: George Fountzilas, et al.
Published: (2012-01-01)

In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients.
by: Maria Vassilakopoulou, et al.
Published: (2014-01-01)

The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases
by: Stacey A. Cohen, et al.
Published: (2017-05-01)

Glycogen-rich clear cell carcinoma of the breast
by: Hatzinikolaou ML, et al.
Published: (2008-04-01)

Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS)
by: Kotoula Vassiliki, et al.
Published: (2012-08-01)

Hypoprolactinemia as a Clue to Diagnosis of Mild Central Hypothyroidism due to IGSF1 Deficiency
by: Anastasios Papadimitriou, et al.
Published: (2020-06-01)

Hypercompositional Algebra, Computer Science and Geometry
by: Gerasimos Massouros, et al.
Published: (2020-08-01)

An Overview of the Foundations of the Hypergroup Theory
by: Christos Massouros, et al.
Published: (2021-04-01)

Restorative justice for minors in Greece : the impact of Act 3189/2003
by: Papadopoulou, Panagiota Christos
Published: (2008)